Topics
High-grade gliomas | Treatment | Targeted therapy | Larotrectinib
Home > Publications > Topics > High-grade gliomas > Treatment > Targeted therapy > Larotrectinib
Simoneau J, Robertson P, Muraszko K, Maher CO, Garton H, Calvert
R, Koschmann C, Upadhyaya SA, Mody R, Brown N, Kumar-Sinha C,
Parmar H, Camelo-Piragua S, Franson AT.
Long-Term
Tumor Stability After First-Line Treatment With
Larotrectinib in an Infant With NTRK2
Fusion-Positive High-Grade Glioma.
J
Natl Compr
Canc Netw. 2024 Sep;22(7):e247045. doi:
10.6004/jnccn.2024.7045. PMID:
39236755. Case report. ˍ